The Significance of Sentinel Node Analysis in Colon Cancer
NCT ID: NCT00419978
Last Updated: 2008-07-04
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
NA
24 participants
INTERVENTIONAL
2004-06-30
2008-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Lymphatic Mapping and Sentinel Lymph Node Biopsy in the Treatment of Colorectal Cancer
NCT00005640
Lymphatic Mapping, Sentinel Lymph Node Analysis, and Blood Tests in Detecting and Predicting Early Micrometastases in Patients With Colorectal Cancer
NCT00625625
Minimally INvasive Colon Cancer Surgery Through IMmunomics and Optical Mapping of the Sentinel Lymph Node.
NCT03779009
Sentinel Lymph Node Mapping and Analysis in Colon Cancer Using Indocyanine Green Dye
NCT04351009
Sentinel Node and Organ-sparing Surgery in Stage I Colon Carcinoma
NCT06652672
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
SINGLE_GROUP
TREATMENT
NONE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Colectomy
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients will be tracked for five years
* A blood test (CEA) will be collected every six months
* A CT scan will be performed annually
* A colonoscopy will be performed at 1 and 5 years post-surgery
18 Years
85 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Legacy Health System
OTHER
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Mark Whiteford, MD
Role: PRINCIPAL_INVESTIGATOR
Legayc Health System
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Legacy Good Samaritan Hospital and Medical Center
Portland, Oregon, United States
Countries
Review the countries where the study has at least one active or historical site.
Related Links
Access external resources that provide additional context or updates about the study.
Legacy's internet website
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
750040399
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.